The 2024 data indicates that Luxembourg leads with a significant proportion of scientific publications ranked within the world's top 10% most-cited in drug discovery, followed by Ireland and Egypt. Notably, traditional powerhouses such as the United States and Germany are positioned mid-ranking, indicating a potential shift in research impact towards smaller or emerging countries.
Future trends to watch include:
- Increasing contributions from smaller or emerging nations in high-impact research, possibly driven by targeted investments in innovation.
- Potential changes in the global research landscape due to collaborative efforts and international partnerships.
- Potential advancements and focus shifts in drug discovery as countries leverage new technologies and methods.
Top countries in Share of Scientific Publications Among the World's 10% Top-Cited Publications in Drug Discovery by Country
| # | 10 Countries | Percent | Last Year | |
|---|---|---|---|---|
| 1 | 1 Luxembourg | 34.45 | 2023 | View data |
| 2 | 2 Ireland | 27.15 | 2023 | View data |
| 3 | 3 Egypt | 24.46 | 2023 | View data |
| 4 | 4 Finland | 22.13 | 2023 | View data |
| 5 | 5 Portugal | 20.08 | 2023 | View data |
| 6 | 6 Singapore | 19.3 | 2023 | View data |
| 7 | 7 Latvia | 18.51 | 2023 | View data |
| 8 | 8 Saudi Arabia | 16.9 | 2023 | View data |
| 9 | 9 Romania | 15.65 | 2023 | View data |
| 10 | 10 United States | 15.61 | 2023 | View data |
